Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Capital Expenditures: 2015-2025

Historic Capital Expenditures for Assembly Biosciences (ASMB) over the last 5 years, with Sep 2025 value amounting to $42,000.

  • Assembly Biosciences' Capital Expenditures was N/A to $42,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $141,000, marking a year-over-year change of. This contributed to the annual value of $28,000 for FY2024, which is 89.02% down from last year.
  • Assembly Biosciences' Capital Expenditures amounted to $42,000 in Q3 2025, which was up 200.00% from $14,000 recorded in Q2 2024.
  • In the past 5 years, Assembly Biosciences' Capital Expenditures ranged from a high of $3.1 million in Q1 2021 and a low of $14,000 during Q1 2024.
  • For the 3-year period, Assembly Biosciences' Capital Expenditures averaged around $54,167, with its median value being $45,000 (2023).
  • Its Capital Expenditures has fluctuated over the past 5 years, first skyrocketed by 4,635.38% in 2021, then slumped by 70.83% in 2024.
  • Quarterly analysis of 5 years shows Assembly Biosciences' Capital Expenditures stood at $18,000 in 2021, then reached $102,000 in 2022, then skyrocketed by 33.33% to $71,000 in 2023, then slumped by 70.83% to $14,000 in 2024, then reached $42,000 in 2025.
  • Its last three reported values are $42,000 in Q3 2025, $14,000 for Q2 2024, and $14,000 during Q1 2024.